These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Markers associated with inborn errors of metabolism of branched-chain amino acids and their relevance to upper levels of intake in healthy people: an implication from clinical and molecular investigations on maple syrup urine disease. Mitsubuchi H; Owada M; Endo F J Nutr; 2005 Jun; 135(6 Suppl):1565S-70S. PubMed ID: 15930470 [TBL] [Abstract][Full Text] [Related]
3. Living related versus deceased donor liver transplantation for maple syrup urine disease. Feier F; Schwartz IV; Benkert AR; Seda Neto J; Miura I; Chapchap P; da Fonseca EA; Vieira S; Zanotelli ML; Pinto e Vairo F; Camelo JS; Margutti AV; Mazariegos GV; Puffenberger EG; Strauss KA Mol Genet Metab; 2016 Mar; 117(3):336-43. PubMed ID: 26786177 [TBL] [Abstract][Full Text] [Related]
4. Successful treatment of severe MSUD in Bckdhb Pontoizeau C; Gaborit C; Tual N; Simon-Sola M; Rotaru I; Benoist M; Colella P; Lamazière A; Brassier A; Arnoux JB; Rötig A; Ottolenghi C; de Lonlay P; Mingozzi F; Cavazzana M; Schiff M J Inherit Metab Dis; 2024 Jan; 47(1):41-49. PubMed ID: 36880392 [TBL] [Abstract][Full Text] [Related]
5. Production and characterization of murine models of classic and intermediate maple syrup urine disease. Homanics GE; Skvorak K; Ferguson C; Watkins S; Paul HS BMC Med Genet; 2006 Mar; 7():33. PubMed ID: 16579849 [TBL] [Abstract][Full Text] [Related]
6. Neonatal gene therapy achieves sustained disease rescue of maple syrup urine disease in mice. Pontoizeau C; Simon-Sola M; Gaborit C; Nguyen V; Rotaru I; Tual N; Colella P; Girard M; Biferi MG; Arnoux JB; Rötig A; Ottolenghi C; de Lonlay P; Mingozzi F; Cavazzana M; Schiff M Nat Commun; 2022 Jun; 13(1):3278. PubMed ID: 35672312 [TBL] [Abstract][Full Text] [Related]
7. Diagnosis and treatment of maple syrup disease: a study of 36 patients. Morton DH; Strauss KA; Robinson DL; Puffenberger EG; Kelley RI Pediatrics; 2002 Jun; 109(6):999-1008. PubMed ID: 12042535 [TBL] [Abstract][Full Text] [Related]
8. Treatment of maple syrup urine disease: Benefits, risks, and challenges of liver transplantation. Deon M; Guerreiro G; Girardi J; Ribas G; Vargas CR Int J Dev Neurosci; 2023 Oct; 83(6):489-504. PubMed ID: 37340513 [TBL] [Abstract][Full Text] [Related]
9. PPM1K defects cause mild maple syrup urine disease: The second case in the literature. Ozcelik F; Arslan S; Ozguc Caliskan B; Kardas F; Ozkul Y; Dundar M Am J Med Genet A; 2023 May; 191(5):1360-1365. PubMed ID: 36706222 [TBL] [Abstract][Full Text] [Related]
10. Branched-chain amino acid metabolism: from rare Mendelian diseases to more common disorders. Burrage LC; Nagamani SC; Campeau PM; Lee BH Hum Mol Genet; 2014 Sep; 23(R1):R1-8. PubMed ID: 24651065 [TBL] [Abstract][Full Text] [Related]
12. Adipose transplant for inborn errors of branched chain amino acid metabolism in mice. Zimmerman HA; Olson KC; Chen G; Lynch CJ Mol Genet Metab; 2013 Aug; 109(4):345-53. PubMed ID: 23800641 [TBL] [Abstract][Full Text] [Related]
13. Three Korean patients with maple syrup urine disease: four novel mutations in the BCKDHA gene. Park HD; Lee DH; Hong YH; Kang DH; Lee YK; Song J; Lee SY; Kim JW; Ki CS; Lee YW Ann Clin Lab Sci; 2011; 41(2):167-73. PubMed ID: 21844576 [TBL] [Abstract][Full Text] [Related]
14. Brain Branched-Chain Amino Acids in Maple Syrup Urine Disease: Implications for Neurological Disorders. Xu J; Jakher Y; Ahrens-Nicklas RC Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050626 [TBL] [Abstract][Full Text] [Related]
15. Muscle-directed AAV gene therapy rescues the maple syrup urine disease phenotype in a mouse model. Greig JA; Jennis M; Dandekar A; Chorazeczewski JK; Smith MK; Ashley SN; Yan H; Wilson JM Mol Genet Metab; 2021; 134(1-2):139-146. PubMed ID: 34454844 [TBL] [Abstract][Full Text] [Related]
16. Developmental Defects of Caenorhabditis elegans Lacking Branched-chain α-Ketoacid Dehydrogenase Are Mainly Caused by Monomethyl Branched-chain Fatty Acid Deficiency. Jia F; Cui M; Than MT; Han M J Biol Chem; 2016 Feb; 291(6):2967-73. PubMed ID: 26683372 [TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and mutation analysis of five Chinese patients with maple syrup urine disease. Li X; Yang Y; Gao Q; Gao M; Lv Y; Dong R; Liu Y; Zhang K; Gai Z Metab Brain Dis; 2018 Jun; 33(3):741-751. PubMed ID: 29307017 [TBL] [Abstract][Full Text] [Related]
18. Regulation of the branched-chain alpha-ketoacid dehydrogenase and elucidation of a molecular basis for maple syrup urine disease. Harris RA; Zhang B; Goodwin GW; Kuntz MJ; Shimomura Y; Rougraff P; Dexter P; Zhao Y; Gibson R; Crabb DW Adv Enzyme Regul; 1990; 30():245-63. PubMed ID: 2403034 [TBL] [Abstract][Full Text] [Related]